Anemia post-lung transplantation: Mechanisms and approach to diagnosis

Chronic Respiratory Disease

Volumn 7, Issue 1, 2010, Pages 29-34

  Modrykamien, Ariel ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; DAPSONE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; VALACICLOVIR; VALGANCICLOVIR;

ALGORITHM; ANEMIA; BLEEDING; BONE MARROW SUPPRESSION; CELL INFILTRATION; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; ERYTHEMA INFECTIOSUM; ERYTHROCYTE APLASIA; FOLIC ACID DEFICIENCY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; IMMUNE MEDIATED INJURY; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RECIPIENT; RETICULOCYTE COUNT; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS INFECTION;

ANEMIA; HUMANS; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 76649143739     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972309354688     Document Type: Review

References (35)

1. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968 ; 405: 5-37.
2. Tager AM, LC Ginns. Complications of lung transplantation. Crit Care Nurs Clin North Am 1996 ; 8: 273-292.
3. Vicente R., Morales P., Ramos F., Solé A., Mayo M., Villalain C. Perioperative complications of lung transplantation in patients with emphysema and fibrosis: experience from 1992-2002. Transplant Proc 2006 ; 38: 2560-2562.
4. Ferrer J., Roldan J., Roman A., et al. Acute and chronic pleural complications in lung transplantation. J Heart Lung Transplant 2003 ; 22: 1217-1225.
5. Bapat AR, Schuster SJ, Dahlke M., Ballas SK Thrombocytopenia and autoimmune hemolytic anemia following renal transplantation. Transplantation 1987 ; 44: 157-159.
6. Salerno CT, Burdine J., Perry EH, Kshettry VR, Hertz MI, Bolman RM 3rd. Donor-derived antibodies and hemolysis after ABO-compatible but nonidentical heart-lung and lung transplantation. Transplantation 1998 ; 65: 261-264.
7. Panaro F., DeChristopher PJ, Rondelli D., et al. Severe hemolytic anemia due to passenger lymphocytes after living-related bowel transplant. Clin Transplant 2004 ; 18: 332-335.
8. Taaning E., Morling N., Mortensen SA, Pettersson G., Simonsen AC Hemolytic anemia due to graft-derived anti-B production after lung transplantation. Transplant Proc 1994 ; 26: 1739.
9. Sokol RJ, Stamps R., Booker DJ, et al. Posttransplant immune-mediated hemolysis. Transfusion 2002 ; 42: 198-204.
10. Ramsey G. Red cell antibodies arising from solid organ transplants. Transfusion 1991 ; 31: 76-86.
11. McMillan MA, Muirhead CS, Lucie NP, Briggs JD, Junor BJ Autoimmune haemolytic anaemia related to cyclosporin with ABO-compatible kidney donor and recipient. Nephrol Dial Transplant 1991 ; 6: 57-59.
12. Fabrega AJ, DeChristopher J., Sosler SD, Rivas PA, Vasquez EM, Pollak R. Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation: contributory role of HLA matching and polyclonal antilymphocyte globulin. Clin Transplant 1996 ; 10: 166-169.
13. Riechsteiner G., Speich R., Schanz U., Russi EW, Weder W., Boehler A. Haemolytic anaemia after lung transplantation: an immune-mediated phenomenon? Swiss Med Wkly 2003 ; 133: 143-147.
14. Singh N., Gayowski T., Marino IR Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int 1996 ; 9: 68-75.
15. Ramasubbu K., Mullick T., Koo A., Hussein M., et al. Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case-based review. Transpl Infect Dis 2003 ; 5: 98-103.
16. Franz M., Regele H., Schmaldienst S., Stummvoll HK, Hörl WH, Pohanka E. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? Transplantation 1998 ; 66: 1258-1262.
17. Mach-Pascual S., Samii K., Beris P. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. Am J Hematol 1996 ; 52: 310-312.
18. Rerolle JP, Akposso K., Lerolle N., et al. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation. Clin Transplant 2000 ; 14: 262-265.
19. Cohen H., Bull HA, Seddon A., et al. Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation. Eur J Haematol 1989 ; 43: 207-214.
20. Lieberman KV, Lin WG, Reisman L. FK 506 is a direct glomeruloconstrictor, as determined by electrical resistance pulse sizing (ERPS). Transplant Proc 1991 ; 23: 3119-3120.
21. Moutabarrik A., Ishibashi M., Fukunaga M., et al. FK506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells. Transpl Int 1992 ; 5 Suppl 1: S93 - S97.
22. Reid DW, Street A., Mansfield D., et al. Microangiopathic haemolytic anaemia and thrombocytopenia following lung volume reduction surgery in a single lung transplant recipient on maintenance tacrolimus (FK506) therapy. Respirology 2003 ; 8: 243-245.
23. Myers JN Shabshab SF, Burton NA, Nathan SD Successful use of cyclosporine in a lung transplant recipient with tacrolimus-associated hemolytic uremic syndrome. J Heart Lung Transplant 1999 ; 18: 1024-1026.
24. Ho DD, Rota TR, Andrews CA, Hirsch MS Replication of human cytomegalovirus in endothelial cells. J Infect Dis 1984 ; 150: 956-957.
25. Grefte JM, van der Giessen M., Blom N., The TH, van Son WJ Circulating cytomegalovirus-infected endothelial cells after renal transplantation: possible clue to pathophysiology? Transplant Proc 1995 ; 27: 939-942.
26. Doherty M., Bradfield JW Polyarteritis nodosa associated with acute cytomegalovirus infection. Ann Rheum Dis 1981 ; 40: 419-421.
27. Murer L., Zacchello G., Bianchi D., et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol. 2000 ; 11: 1132-1137.
28. Balfour HH Jr. Antiviral drugs. N Engl J Med 1999 ; 340: 1255-1268.
29. Geetha D., Zachary JB, Baldado HM, Kronz JD, Kraus ES Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 2000 ; 14: 586-591.
30. Baranski B., Armstrong G., Truman JT, Quinnan GV Jr, Straus SE, Young NS Epstein-Barr virus in the bone marrow of patients with aplastic anemia. Ann Intern Med 1988 ; 109: 695-704.
31. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994 ; 331: 1110-1115.
32. Maheshwari A., Mishra R., Thuluvath PJ Post-liver-transplant anemia: etiology and management. Liver Transpl 2004 ; 10: 165-173.
33. Apperley JF, Dowding C., Hibbin J., et al. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp Hematol 1989 ; 17: 38-45.
34. Eid AJ, Brown RA, Patel R., Razonable RR Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis 2006 ; 43: 40-48.
35. Gottschalk S., Rooney CM, Heslop HE Post-transplant lymphoproliferative disorders. Annu Rev Med 2005 ; 56: 29-44.